Select Page

IMLYGIC (talimogene laherparepvec) Suspension for intralesional injection Initial U.S. Approval: 2015

IMLYGIC (talimogene laherparepvec) Suspension for intralesional injection Initial U.S. Approval: 2015

IMLYGIC is a Anti Cancer medicine. IMLYGIC is used to treat melanoma.
INDICATIONS AND USAGE
IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery.
Limitations of use: IMLYGIC has not been shown to improve overall survival or have an effect on visceral metastases.
DOSAGE FORMS & STRENGTHS
Injection: 106 (1 million) PFU per mL, 108 (100 million) PFU per mL in single-use vials.
Manufactured By: Amgen
Prescribing Information URL: Click Here

Procedure to buy IMLYGIC (talimogene laherparepvec)?
To buy IMLYGIC (talimogene laherparepvec), patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Talimogene laherparepvec[a] is a biopharmaceutical drug to treat melanoma that cannot be operated on; it is injected directly into a subset of lesions which generates a systemic immune response against the patient's cancer. The drug was created and initially developed by BioVex, Inc. and was continued by Amgen, which acquired BioVex in 2011. It was the first oncolytic immunotherapy approved globally; it was approved in the US in October 2015 and approved in Europe in December 2015.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

IMLYGIC (talimogene laherparepvec) in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
IMLYGIC (talimogene laherparepvec) in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
IMLYGIC (talimogene laherparepvec) in North America – Mexico.
IMLYGIC (talimogene laherparepvec) in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
IMLYGIC (talimogene laherparepvec) in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
IMLYGIC (talimogene laherparepvec) in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
IMLYGIC (talimogene laherparepvec) in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
IMLYGIC (talimogene laherparepvec) in Australia and New Zealand.

For Indian Patient

Ani-Cancer IMLYGIC (talimogene laherparepvec) are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

IMLYGIC (talimogene laherparepvec) can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “IMLYGIC (talimogene laherparepvec) Suspension for intralesional injection Initial U.S. Approval: 2015”

Your email address will not be published. Required fields are marked *

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.